Informazioni sui membri
Dr Mikk Pauklin
Rappresentante
Estonia
Gruppi di lavoro: Malattie rare dell'occhio del segmento anteriore (WG4)
Team
Dr Laura Mauring
Estonia
Diagnostica genetica (TWG6), Malattie rare dell'oftalmologia pediatrica (WG3), Malattie rare dell'occhio della retina (WG1)
Centro HCP
L'Ospedale Universitario di Tartu è il più grande fornitore di assistenza sanitaria in Estonia. L'assistenza medica terziaria di alta qualità è offerta in quasi tutti...
contatti
Test clinici
NCT04435366 Completato
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
interventistica
NCT04423718 Attivo, non reclutante
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
interventistica
NCT04270747 Completato
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
interventistica
NCT04939571 Reclutamento, attivo
European Disease Registry on Retinopathy of Prematurity (ROP)
osservazionale